Categories
Pharmaceutical

Cardiology Genomic Testing Market to Reap Excessive Revenues through 2021-2031; Rising Prevalence of Cardiac Arrhythmias and Atherosclerosis to Fuel Market Demand

Heart disorders can be inherited and passed from parents to children via their genes. Cardiology genomic testing helps in detecting diseases such as aortopathy and congenital heart diseases. Also, it can be useful for family members who are at a risk of developing heart problems. Genetic disorders affect the development of blood vessels and lead to heart diseases.The growing prevalence of heart diseases such as cardiac arrhythmias and atherosclerosis is expected to be the major factor driving the growth of the cardiology genomic testing market over the forecast period.

The Market Research Survey by “Fact.MR, A Market Research and Competitive Intelligence Provider” highlights the key reasons behind increasing demand of Cardiology Genomic Testing. Cardiology Genomic Testing market drivers and constraints, threats and opportunities, regional segmentation and opportunity assessment, end-use/application prospects review are addressed in the Cardiology Genomic Testing market survey report. The survey report provides a comprehensive analysis of Cardiology Genomic Testing market key trends and insights on Cardiology Genomic Testing market size and share.

To Get In-depth Insights Request for Brochure here – https://www.factmr.com/connectus/sample?flag=B&rep_id=2565

Cardiology Genomic Testing Market: Key Players

The global market for cardiology genomic testing is highly fragmented. Examples of some of the key players operating in cardiology genomic testing kits are Color Genomics, Inc. Thermo Fisher Scientific, Admera Health, Helix OpCo LLC, Blueprint Genetics Oy. Illumina, Inc., Gnome Diagnostics, Creative Diagnostics, Merck KGaA, MP Biomedicals, LLC., CENTOGENE AG, and Oasis Diagnostics Corporation among others.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, and inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments.

Key questions answered in Cardiology Genomic Testing Market Survey Report:

  1. What is the current scenario and key trends in Cardiology Genomic Testing Market?
  2. What are the key strategies companies are adopting to increase their consumer base?
  3. What are the key categories within the Cardiology Genomic Testing segments and their future potential?
  4. What are the major Cardiology Genomic Testing Market drivers and their expected impact during the short, medium, and long terms?
  5. What is the Cardiology Genomic Testing Market size and what are the opportunities for the key players?

Request Customized Report as Per Your Requirements – https://www.factmr.com/connectus/sample?flag=RC&rep_id=2565

Cardiology Genomic Testing Market: Segmentation

Tentatively, the global cardiology genomic testing market can be segmented on the basis of sample type, type of testing and diagnosis, application, and end user.

Based on sample type, the global cardiology genomic testing market is segmented as:

  • Saliva
  • Blood
  • Cheek Swabs

Based on testing and diagnosis, the global cardiology genomic testing market is segmented as:

  • Genetic Screening
  • Pre-symptomatic Genetic Testing

Based on application, the global cardiology genomic testing market is segmented as:

  • Cardiomyopathies
  • Arrhythmias
  • Aortopathy
  • Other Cardiac Disorders

Based on end user, the global cardiology genomic testing market is segmented as:

  • Hospitals
  • Diagnostic Laboratories
  • Specialized Centers

Essential Takeaways from the this Market Report

  • Comparison of prominent players operating in the market.
  • Recent developments and key strategies adopted by key players.
  • Study of the micro and macro-economic growth indicators.
  • Impact of the various factors on the value chain.
  • Evaluation of current Cardiology Genomic Testing market size, forecast and technological advancements within the industry.
  • Current Insights influencing the scenario and key trends in Cardiology Genomic Testing market.

Enquire Before Buying Here – https://www.factmr.com/connectus/sample?flag=EB&rep_id=2565

The Report Covers Exhaustive Analysis On:

  • Cardiology Genomic Testing Market Drivers, Segments and Restraints.
  • Cardiology Genomic Testing Market Survey and Dynamics
  • Cardiology Genomic Testing Market Size & Demand
  • Cardiology Genomic Testing Key Trends/Issues/Challenges
  • Cardiology Genomic Testing Sales, Competition & Companies involved

Watch Trending Video on Free Mindfulness Meditation Apps Market-2031 – https://www.youtube.com/watch?v=MCEzxHyNzHc

Explore Fact.MR’s Coverage on the Healthcare Domain:

Brain Implant Market– According to latest research by Fact.MR, brain implants market is observer stead growth during 2021-2031. Demand for brain implant expects to witness steady recovery in the short-term, with an optimistic growth outlook in the long run.

Artificial Retina Market– According to the latest research by Fact.MR, the artificial retina market is observed steady growth during 2021-2031. Demand for artificial retina expects to grow in the forecast period with steady growth.

Anti-Snoring Treatment Market– According to the latest research by Fact.MR, the anti-snoring treatment market is set to witness steady growth during 2021-2031. Demand for anti-snoring treatment expects to witness steady recovery in the short-term, with an optimistic growth outlook in the longrun.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Categories
Pharmaceutical

Live Cell Analysis System Market to Remain Lucrative during 2021-2031; Increasing Government Funding for R&D in Life Science Laboratories to Propel Market Growth

The live cell analysis system enables real-time visualization and qualitative and quantitative estimation of the live cell. With advancement in technology, high resolution imaging and analysis platform allow the study of morphology, behaviour and timeline of the cell cycle and biological processes of the target cells. The live cell analysis system gathers the required information and automatically performs the analysis.The growing research in cell biology, genetics and molecular biology, drug designing and developmental and tissue culture biology is expected to fuel the growth of the live cell analysis system market.

The Market Research Survey by “Fact.MR, A Market Research and Competitive Intelligence Provider” highlights the key reasons behind increasing demand of Live Cell Analysis System. Live Cell Analysis System market drivers and constraints, threats and opportunities, regional segmentation and opportunity assessment, end-use/application prospects review are addressed in the Live Cell Analysis System market survey report. The survey report provides a comprehensive analysis of Live Cell Analysis System market key trends and insights on Live Cell Analysis System market size and share.

To Get In-depth Insights Request for Brochure here – https://www.factmr.com/connectus/sample?flag=B&rep_id=2564

Live Cell Analysis System Market: Segmentation

The global live cell analysis system market has been segmented on the basis of visualisation mode, application and end user.

Based on visualisation mode, the global live cell analysis system market is segmented as:

  • 2D
  • 3D

Based on application, the global live cell analysis system market is segmented as:

  • Developmental Biology
  • Cancer Research
  • Genetics and Molecular Biology
  • Drug Designing
  • Tissue Culture Biology

Based on end user, the global live cell analysis system market is segmented as:

  • Research and Development Laboratories
  • Academic and Educational Institutes
  • Cancer Research Laboratories

Key questions answered in Live Cell Analysis System Market Survey Report:

  1. What is the current scenario and key trends in Live Cell Analysis System Market?
  2. What are the key strategies companies are adopting to increase their consumer base?
  3. What are the key categories within the Live Cell Analysis System segments and their future potential?
  4. What are the major Live Cell Analysis System Market drivers and their expected impact during the short, medium, and long terms?
  5. What is the Live Cell Analysis System Market size and what are the opportunities for the key players?

Request Customized Report as Per Your Requirements – https://www.factmr.com/connectus/sample?flag=RC&rep_id=2564

Live Cell Analysis System Market: Key Players

Examples of some of the key players operating in the global live cell analysis system market are ACEA Biosciences, Inc. (Agilent Technologies), Essen BioScience Inc. (Sartorius), Etaluma, Inc. (MDS Analytical Technologies, Inc.), Carl-Zeiss-Stiftung, Leica Microsystems (Danaher Corporation), Molecular Devices, LLC., Becton, Dickinson and Company, Seahorse Bioscience (Agilent Technologies), Merck Group (E. Merck KG), BioVision Technologies, Inc., and Nanolive SA, among others.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments.

Essential Takeaways from the this Market Report

  • Comparison of prominent players operating in the market.
  • Recent developments and key strategies adopted by key players.
  • Study of the micro and macro-economic growth indicators.
  • Impact of the various factors on the value chain.
  • Evaluation of current Live Cell Analysis System market size, forecast and technological advancements within the industry.
  • Current Insights influencing the scenario and key trends in Live Cell Analysis System market.

Enquire Before Buying Here – https://www.factmr.com/connectus/sample?flag=EB&rep_id=2564

Live Cell Analysis System Market: Regional Outlook

Geographically, the global live cell analysis system market is segmented into North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America is projected to hold large share of the global live cell analysis system market primarily due to the presence of a large number of research and development centres, biotechnology and tissue culture laboratories and increasing funding for research.

The Report Covers Exhaustive Analysis On:

  • Live Cell Analysis System Market Drivers, Segments and Restraints.
  • Live Cell Analysis System Market Survey and Dynamics
  • Live Cell Analysis System Market Size & Demand
  • Live Cell Analysis System Key Trends/Issues/Challenges
  • Live Cell Analysis System Sales, Competition & Companies involved

Watch Trending Video on High Purity Quartz Sand Industry Survey Report by Fact.MR – https://www.youtube.com/watch?v=ItwHQrt-vmY

Explore Fact.MR’s Coverage on the Healthcare Domain:

Hemostasis Valves Market – According to the latest research by Fact.MR, the Hemostasis Valves Market is set to witness steady growth during 2021-2031. The increasing advancement in the hemostasis valves industry will offer lucrative opportunities and an increasing number of interventional procedures is propelling the market growth.

Cosmetic Dentistry Market – The global cosmetic dentistry market is estimated to witness significant growth during the forecast period of 2021-2031. This growth is factored in due to the rising consumer awareness and well-defined grooming interest in the aesthetical value of oral care.

Creatinine Testing Market– Creatinine testing involves the measurement of the level of creatinine, which is a product of muscle creatine catabolism and is thus a reliable indicator of kidney function by an indication that a rise in the level of creatinine may indicate Acute Kidney Injury or Chronic Kidney Disease.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Categories
Pharmaceutical

Increasing R&D and Usage of HPLC Machines in Drug Development Process to Uptick the Demand of HPLC Fused Silica Tube Market: States Fact.MR Report

High performance liquid chromatography (HPLC) is a chromatography technique in which the sample mixture is pumped at a high pressure, which further passes through a stationary phase column. The device HPLC has the potential to separate and differentiate the compounds dissolved in liquid in minute concentrations based on its size.Increasing usage of HPLC machines in major sectors such as pharmaceutical and biopharmaceutical, food industry, forensic analysis, environment analysis is likely to fuel the growth of the global HPLC fused silica tube market.

The Market Research Survey by “Fact.MR, A Market Research and Competitive Intelligence Provider” highlights the key reasons behind increasing demand of HPLC Fused Silica Tube. HPLC Fused Silica Tube market drivers and constraints, threats and opportunities, regional segmentation and opportunity assessment, end-use/application prospects review are addressed in the HPLC Fused Silica Tube market survey report. The survey report provides a comprehensive analysis of HPLC Fused Silica Tube market key trends and insights on HPLC Fused Silica Tube market size and share.

To Get In-depth Insights Request for Brochure here – https://www.factmr.com/connectus/sample?flag=B&rep_id=2563

HPLC Fused Silica Tube Market: Segmentation

Tentatively, the global HPLC fused silica tube market can be segmented on the basis of product type, application, end user, and geography.

Based on Product type, the global HPLC fused silica tube market is segmented as:

  • Activated fused silica tubing
  • Deactivated fused silica tubing

Based on Application, the global HPLC fused silica tube market is segmented as:

  • Liquid Chromatography (LC)
  • Capillary Liquid Chromatography

Based on End User, the global HPLC fused silica tube market is segmented as:

  • Research Centers and laboratories
  • Academic Institutes
  • Biopharmaceutical and pharmaceutical companies
  • Forensic departments
  • Environmental Industry
  • Contract Research Organizations (CROs)
  • Food and Beverage industry

Key questions answered in HPLC Fused Silica Tube Market Survey Report:

  1. What is the current scenario and key trends in HPLC Fused Silica Tube Market?
  2. What are the key strategies companies are adopting to increase their consumer base?
  3. What are the key categories within the HPLC Fused Silica Tube segments and their future potential?
  4. What are the major HPLC Fused Silica Tube Market drivers and their expected impact during the short, medium, and long terms?
  5. What is the HPLC Fused Silica Tube Market size and what are the opportunities for the key players?

Request Customized Report as Per Your Requirements – https://www.factmr.com/connectus/sample?flag=RC&rep_id=2563

HPLC Fused Silica Tube Market: Key Players

The global market for HPLC fused silica tube Market is highly fragmented. Examples of some of the key players operating in the global HPLC fused silica tube market are Merck KGaA, Trajan Scientific and Medical, Thermo Fisher Scientific, Valco Instruments Co. Inc., Scientific Instrument Services, Inc., Restek Corporation, Agilent Technologies, WATERS, Kinesis Ltd., PerkinElmer Inc., and Chrom Tech, Inc., among others.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments.

Essential Takeaways from the this Market Report

  • Comparison of prominent players operating in the market.
  • Recent developments and key strategies adopted by key players.
  • Study of the micro and macro-economic growth indicators.
  • Impact of the various factors on the value chain.
  • Evaluation of current HPLC Fused Silica Tube market size, forecast and technological advancements within the industry.
  • Current Insights influencing the scenario and key trends in HPLC Fused Silica Tube market.

Enquire Before Buying Here –  https://www.factmr.com/connectus/sample?flag=EB&rep_id=2563

The Report Covers Exhaustive Analysis On:

  • HPLC Fused Silica Tube Market Drivers, Segments and Restraints.
  • HPLC Fused Silica Tube Market Survey and Dynamics
  • HPLC Fused Silica Tube Market Size & Demand
  • HPLC Fused Silica Tube Key Trends/Issues/Challenges
  • HPLC Fused Silica Tube Sales, Competition & Companies involved

Watch Trending Video on Sodium Formate Industry Survey Report by Fact.MR – https://www.youtube.com/watch?v=MuydFhdcGdA

Explore Fact.MR’s Coverage on the Healthcare Domain:

Medical Coding Market– According to the latest research by Fact.MR, the medical coding market is set to witness significant growth during 2021-2031. Medical coding has always been in demand and is expected to remain at a steady growth in the forecasted period. Medical coding has been in demand in the U.S. as is designed to support Electronic Health Records (EHRs).

Ambulance Services Market– According to the latest research by Fact.MR, the Ambulance Services market is set to witness steady growth during 2021-2031. The market is moderately fragmented and the demand for Ambulance Services will witness stable growth owing to the rising number of medical emergencies, a rapid rise in hospitals visits due to this pandemic as well as regular doctor visits.

mRNA Sequencing Market– According to the latest research by Fact.MR, the mRNA Sequencing market is set to witness steady growth during 2021-2031. The market has been a highly fragmented market developing at a gradual rate and is expected to witness lucrative growth with the increasing utilization of methodologies by major participants; the market is anticipated to increase over the projected skyline.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Categories
Pharmaceutical

Cost Benefits of Artificial Insemination In Asia Pacific are Attracting Reproductive Care Seekers from Across the Globe: Fact.MR

250 Pages of Market Research Survey Report Published by Fact.MR, A Market Research and Competitive Intelligence Provider Highlights Key Factors Driving the Growth of Assisted Reproductive Technology Market Over the Forecast Period 2020-2025

The Fact.MR study on the assisted reproductive technology market offers insights into key factors affecting market growth trajectory. The survey report reveals insights into drivers propelling the demand outlook in terms of Procedure ( Frozen Donor, Frozen Non-Donor, Fresh Donor) , End User (Fertility Clinics, Hospitals), and Technology (In Vitro Fertilization, Artificial Insemination, Surrogacy). The report also highlights the scope of assisted reproductive technology over the assessment period

In-vitro fertilization (IVF) technology would account for an unrivalled patient base, as compared to surrogacy and artificial insemination, on the back of the high success rate of the procedure. The introduction of preimplantation genetic diagnosis (PGD) technology helps medical professionals screen embryos for inherited diseases, which further improves the prospects of conceiving a healthy child.  Conditions such as PCOD/PCOS are found to worsen the reproductive performance of women, which leads to remote chances of conceivability, thereby encouraging women to undergo infertility treatment using assisted reproductive technology. Based on these relevant insights, authors of an exclusive Fact.MR study estimate a CAGR of around 6.3% for the expansion of the assisted reproductive technology market during the forecast period (2020-2025).

Improvement in Predictive Analytics Across Healthcare is Driving the Growth Of Assisted Reproductive Technology Market

Increasing awareness regarding the individual’s health coupled with the ongoing advancement in healthcare infrastructures such as improvement in data science and predictive analytics are creating lucrative growth opportunities for the Assisted Reproductive Technology market.

A subject matter expert at Fact.MR opines, “Currently, Europe, North America, Latin America, and a handful of countries in the Asia Pacific and the Middle East & Africa have regulations protecting the legal rights of the homosexual populace. However, homosexually-close relationships are progressively gaining acceptance in other countries too, which is indicative of the high demand for assisted reproductive technology in future.”

For More Insights Into The Market, Request a Sample of this Report

https://www.factmr.com/connectus/sample?flag=S&rep_id=4393

incremental opportunity analysis in assisted reproductive technology market by procedure

Assisted Reproductive Technology Demand Analysis by Category

Procedure
  • Frozen Donor
  • Frozen Non-donor
  • Fresh Donor
  • Fresh Non-donor
  • Embryo Banking
Technology
  • In-vitro Fertilization
    • Intra-cytoplasmic Sperm Injection (ICSI)
    • Preimplantation Genetic Diagnosis (PGD)
  • Surrogacy
  • Artificial Insemination
    • Intrauterine Insemination (IUI)
    • Intracervical Insemination (ICI)
    • Others
  • Others
End User
  • Fertility Clinics
  • Hospitals
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa


Access Research Methodology Prepared By Experts –

https://www.factmr.com/connectus/sample?flag=RM&rep_id=4393

Key Highlights of Assisted Reproductive Technology Market Study

  • High costs associated with quality IVF and IUI procedures are gradually propelling a shift of patients from assisted reproductive technology towards naturopathic solutions and alternative therapies to treat infertility, which is posing as a threat to developmental efforts of market players.
  • Increasing number of dual working households with a career-intensive approach, in turn, continues to increase reproductive complexity, which is taken into account by major corporates. Efforts have been made by major companies, such as Google LLC, towards creating a conducive environment for female employees by offering facilities to store their eggs, thereby stimulating growth of the assisted reproductive technology market.
  • Initiatives taken by numerous public and private institutions such as ASPIRE are projected to raise awareness and increase the adoption of assisted reproductive technology in Asia Pacific. Public awareness campaigns are also being witnessed in the U.S. by central authorities such as the Society for Assisted Reproductive Technology and National Infertility Association, which is reflecting on the growing patient base for infertility treatment.
  • Cost benefits of artificial reproductive techniques in developing countries of Asia Pacific are attracting reproductive care seekers from across the world. The study finds that, a complete package of surrogacy costs merely one-third of that in the U.K., which is strengthening the position of Asia Pacific as a key surrogacy destination.

Full Access of this Report Is Available At 

https://www.factmr.com/checkout/4393

Cost-effectiveness of Alternative Medicines to Remain Pertinent Threat for Players

Numerous threats and challenges with varying influence are encountered by players in the assisted reproductive technology market, including threats of cost-effective alternative therapies and choice of child adoption. Though entry barriers in the assisted reproductive technology are high, on the back of huge CAPEX and OPEX requirements, intense development activities undertaken by existing players are influential enough to turn the landscape fragmented. For instance, a key player—Nidacon International AB—focuses on product innovation in the sperm diagnostic segment, and, in turn, extends efforts towards upgrading its existing product lines. Collaborations and alliances among leading players are also projected to foster improvements in fertility techniques, thereby leading to advancements in assisted reproductive technology.

Find More Valuable Insights on Assisted Reproductive Technology Market

Fact.MR, in its new offering, brings to the fore an unbiased analysis of the global assisted reproductive technology market, presenting historical demand data (2015-2019), and forecast statistics for the period of 2020-2025. The study divulges compelling insights on the assisted reproductive technology market on the basis of technology (in-vitro fertilization, surrogacy, artificial insemination, and others), procedure (frozen donor, frozen non-donor, fresh donor, fresh non-donor, and embryo banking), and end user (hospitals, fertility clinics, and others), across five major regions in the assisted reproductive technology market.

For More Insights 

https://www.biospace.com/article/legalization-and-strict-regularization-of-medical-cannabis-is-pivotal-for-improved-uptake-of-cannabis-analyzer-market-notes-fact-mr/

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Enzymes & Inhibitors Healthcare Industry Is Now At The Forefront of Biotechnology Production : Report Fact.MR

250 Pages of Market Research Survey Report Published by Fact.MR, A Market Research and Competitive Intelligence Provider Highlights Key Factors Driving the Growth of Recombinant Protein Market Over the Forecast Period 2017-2022

The Fact.MR study on the recombinant protein market offers insights into key factors affecting market growth trajectory. The survey report reveals insights into drivers propelling the demand outlook in terms of Product Type (Immune Checkpoint Regulators, Chemokines ), End Users ( Biopharmaceutical Companies, Contract Research Organizations ). The report also highlights the scope of recombinant protein over the assessment period

A new report published by Fact.MR estimates the global sales of recombinant protein to witness expansion at a moderate CAGR during the forecast period 2017 to 2022. Revenues from the global recombinant protein market will reach nearly US$ 460 Mn by 2022-end.

Through genetic engineering, and cell engineering, recombinant protein are produced from creature body. The recombinant protein technology now stands at the edge of biotechnology production. Becoming the new standard, this technology is witnessing a gradual shift from bulk production procedure towards post-production techniques, which in turn promises an enhanced delivery and stability. The highly effective recombinant proteins play an integral part in treating specific diseases, such as hemophilia. However, blood coagulation factor is excluded, as it possesses an extremely limited source.

A large number of recombinant protein drugs utilized are human proteins. This is mainly to compensate functional proteins in vivo defects, and for increasing the functions of proteins in a body. These factors provide recombinant proteins with substantially higher safety as compared to small molecules, further leading towards higher approval rates.

For More Insights Into The Market, Request a Sample of this Report 

https://www.factmr.com/connectus/sample?flag=S&rep_id=186

The clinical trial periods for recombinant proteins are comparatively shorter than small molecule drugs, which further aids in enhancing patient protection, and renders pharmaceutical companies with a relatively longer exclusive sales time. Factors such as these are driving the development, and demand for recombinant proteins. Recombinant proteins target diseases such as cardiovascular diseases, endocrine diseases, viral diseases, and cancer.

In addition, the global recombinant protein market has a larger extension space, with few approval drugs available without any alternative products in therapeutic areas. These factors might influence growth of the market over the forecast period. However, factors such as technical barriers, financial barriers have made recombinant protein technology expensive. Moreover, replication of recombinant proteins incurs many challenges, as compared to replication of small molecule chemicals. These factors may impede growth of the market in the near future.

Access Research Methodology Prepared By Experts –

https://www.factmr.com/connectus/sample?flag=RM&rep_id=186

Recombinant Protein Demand Analysis by Category

Product Type

  • Immune Checkpoint Regulators
  • Chemokines
  • Growth Factors
  • Cytokines
  • Colony Stimulating Factors
  • Hormones
  • Enzymes & Inhibitors

End User

  • Biopharmaceutical Companies
  • Contract Research Organizations (CROs)
  • Academic & Research Institutes
  • Forensic Science Laboratories
  • Food & Beverage Companies
  • Diagnostic Centers

Application

  • Drug Discovery & Development
  • Basic Research
  • Toxicity Screening
  • Biopharmaceutical Production
  • Drug Screening
  • Tissue Engineering
  • Forensic TestingBasic research will remain the largest application segment in the global recombinant proteins market. Revenues from basic research will reach roughly US$ 270 Mn in revenues by the end of 2022.

Full Access of this Report Is Available At 

https://www.factmr.com/checkout/186

Key Recombinant Protein Survey Highlights and Projections

  1. Toxicity screening, and drug discovery & development will witness the fastest expansion through 2022, based on application of recombinant proteins.
  2. Recombinant protein sales for forensic testing application will exhibit the lowest CAGR in the market through 2022.
  3. North America is projected to remain dominant in the global market for recombinant proteins, with sales poised to account for approximately US$ 150 Mn revenues by 2022-end.
  4. Europe will continue to be the second largest market for recombinant proteins over the forecast period.
  5. The market for recombinant protein in Middle East & Africa (MEA) will exhibit a sluggish expansion through 2022.
  6. Academic & research institutes will remain the most lucrative end-users in the global recombinant proteins market, accounting for more than one-third revenue share of the market throughout the forecast period.
  7. Biopharmaceutical companies will continue to be the fastest expanding end-users of recombinant proteins in the global market.
  8. Although growth factors are estimated to remain the largest product segment, sales of chemokines will register the fastest expansion through 2022.

For More Insights

https://www.biospace.com/article/how-demand-for-renovascular-hypertension-treatment-growth-spurred-by-increasing-prevalence-of-kidney-disorders-opines-fact-mr/

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Adoption of Drug Eluting Balloon Catheter to Surge Owing to the Increased In Demand for the Treatment of Coronary Artery Disease

Fact MR analysis of Drug Eluting Balloon Catheter market provides compelling insights into the factors propelling sales prospects in key segments such as Indication (Coronary Artery Disease,Peripheral Vascular Diseas), End User ( Hospitals,Ambulatory Surgical Centers,Cardiac Catheterization Laboratories), and Raw Material ( Polyurethan,Nylon). It provides an executive-level blueprint of key market players’ strategies and analyses their impact on overall growth projections.

Drug eluting balloon catheter is witnessing robust adoption owing to its overwhelming results in cardiovascular and peripheral artery procedures. Moreover, drug eluting balloon catheter is also turning out to be useful for patients who are unable to undergo percutaneous coronary intervention (PCI) procedures.

Encouraged by this situation, various drug eluting balloon catheter manufacturers across the globe are now increasing their production capacity. The aforementioned factors are reflecting favorably on the global sales of the drug eluting balloon catheter.

Also, companies are aiming to manufacture cost-effective catheters in order to increase market penetration. The growing prevalence of cardiovascular diseases and soaring incidences of cardiology intervention procedures is facilitating the growth of the global drug-eluting balloon catheter market.

For More Insights Into The Market, Request a Sample of this Report

https://www.factmr.com/connectus/sample?flag=S&rep_id=146

Improvement in Predictive Analytics Across Healthcare is Driving the Growth Of Drug Eluting Balloon Catheter Market

Increasing awareness regarding the individual’s health coupled with the ongoing advancement in healthcare infrastructures such as improvement in data science and predictive analytics are creating lucrative growth opportunities for the Drug Eluting Balloon Catheter market.

Fact.MR projects that the global market for drug eluting balloon catheter will surge at a robust CAGR between 2018 and 2022. In addition, factors such as enhanced reimbursement policies, rising geriatric population, and growing healthcare expenditure are anticipated to positively impact the market’s growth.

The arrival of new-generation drug eluting balloon catheters as well as heavier investments in R&D pipelines in order to increase its utility is also anticipated to create lucrative growth opportunities for manufacturers and stakeholders in the global market for drug eluting balloon catheters.

Market Taxonomy

Indicatione
  • Coronary Artery Disease
  • Peripheral Vascular Diseas
End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Catheterization Laboratories
Raw Material
  • Polyurethane
  • Nylon
  • Others

Access Research Methodology Prepared By Experts –

https://www.factmr.com/connectus/sample?flag=RM&rep_id=146

Key Insights From the Report Include: 

  • Among regions, Europe will retain its dominant position in the market over the forecast period. Between 2017 and 2022, the drug eluting balloon catheter market in Europe will reflect a CAGR of 20.5%. Meanwhile, the Asia-Pacific excluding Japan (APEJ) market will also witness robust growth over the next couple of years.
  • By indication, drug eluting balloon catheter will be used mostly for treating coronary artery disease. Currently, the coronary artery disease indication segment will command for more than two-third revenue share of the global market.
  • Hospitals will remain the largest end-user of drug eluting balloon catheter in 2017 and 2022. Sales of drug eluting balloon catheter currently command for close to 73% market share in terms of revenue. Hospitals are one of the most preferred medical settings for undertaking coronary artery and restenosis procedures.
  • By raw material, demand nylon-based drug eluting balloon catheter will continue to gain traction over the assessment period. Currently, sales of nylon-based drug eluting balloon catheter account for close to 54.1% revenue share of the global market. Towards the end of 2022, more than US$ 244 Mn worth of nylon drug eluting balloon catheters are expected to be sold worldwide.

Full Access of this Report Is Available At

https://www.factmr.com/checkout/146

Competition Tracking

  • Cardionovum GmbH
  • Cook Medical INC
  • Cordis Corporation
  • Abbott Laboratories
  • Meril Life Sciences Pvt Ltd
  • Jotech GmbH
  • MicroPort Scientific Corporation
  • Terumo Corporation
  • Boston Scientific Corporation
  • Tokai Medical Products Inc.
  • BIOTRONIK SE & Co. KG
  • B. Braun Melsungen AG
  • Medtronic Plc.

For More Insights

https://www.biospace.com/article/emergence-of-pharma-tech-and-new-product-launches-is-driving-growth-of-global-analytical-gel-permeation-chromatography-market-notes-fact-mr/

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

What Are The Key Strategies Adopted By Players to Sustain Themselves In The Global Knee Reconstruction Implants Market: Latest Medtech Study By Fact.MR

250 Pages Orthopedic Implants Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider

Fact MR analysis of the orthopedic implants market provides compelling insights into the factors propelling sales prospects in key segments such as Product Type, Fixation Type, and End User. It provides an executive-level blueprint of key market players’ strategies and analyses their impact on overall growth projections.

The orthopedic implants market continues to be a promising avenue in the global medical technology space. Emergence of advanced technologies coupled with rise in orthopedic disorders are major growth determinants for the orthopedic implants market. A recent report by Fact.MR envisions the demand for orthopedic implants to record an august 6.5% CAGR over the forecast period 2018 to 2027.

Although surgeries of orthopedic implants incorporating robotics offer reproducible precision and are less invasive, expensiveness of the technology coupled with the requirement for robust, evidence-based studies continues to impede its adoption in orthopedic surgeries.

For More Insights Into The Market, Request a Sample of this Report

https://www.factmr.com/connectus/sample?flag=S&rep_id=990

orthopedic implants market

Global Orthopedic Implants Market: Segmentation

By Product Type

Hip Reconstruction
Knee Reconstruction
Shoulder Implants

By Fixation Type

Cement
Cementless
Hybrid

By End User

Hospitals
Orthopedic Clinics
Ambulatory Surgical Centers

Share Your Requirements & Get Customized Reports – https://www.factmr.com/connectus/sample?flag=RC&rep_id=990

Digital Transformation in Healthcare Presenting Opportunities for Orthopedic Implants Market Growth

Healthcare organizations around the world are deploying digital tools to accommodating changing consumer preferences. They are pressing on solving the long-standing challenge pertaining to care model innovation.

Considering this, the focus on making healthcare affordable and more transparent will increase. Adoption of care model innovation in healthcare will have a profound impact on the Orthopedic Implants market.

Following Questions Answers Covered in the Report are:

  • How will the global Orthopedic Implants Market perform during the forecast period? What will be the market size in terms of value and volume?
  • Which segment will drive the global Orthopedic Implants Market? Which regional market will show extensive growth in the future? What are the reasons?
  • How will the market dynamics change because of the impact of future market opportunities, restraints, and drivers?
  • What are the key strategies adopted by players to sustain themselves in the global Orthopedic Implants Market?
  • How will these strategies influence the market growth and competition?

Access Research Methodology Prepared By Experts – https://www.factmr.com/connectus/sample?flag=RM&rep_id=990

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
  • EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
  • CIS & Russia
  • Japan
  • Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
  • Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa , Rest of MEA)

Revenues from sales of orthopedic implants for hip reconstructed exceeded US$ 16,800 Mn in 2017.

North America’s preeminent in the orthopedic implants market will continue to prevail, states Fact.MR study. According to American Joint Replacement Registry (AJRR), over 7 million America have been associated with knee and hip reconstruction surgeries collectively. Over half revenue share of the market will be accounted by orthopedic implants sales in North America by 2027-end.

The U.S. Food and Drug Administration (FDA) has approved a slew of robotic surgery systems for orthopedic implants, with the da Vinci Surgical System being the first one. More companies have been investing in the technology for providing a better navigation during the procedure, and obtain 3D scans to aid designing of customized joints.

Acquisitions and mergers continue to be key strategic expansion methods adopted by companies operating in the orthopedic implants market. Acquisition of Mako Surgical Corp. by Stryker – for total hip and knee construction robotic products for orthopedic implants, and Blue Belt Holdings by Smith & Nephew for robot-assisted orthopedic implant surgery product for partial knee replacements are prime instances of such strategic expansions.

Explore More Trending Reports of Fact.MR

Pelvic Floor Stimulator Market Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031 ( https://www.factmr.com/report/pelvic-floor-stimulator-market )

Terminal Sterilization Market Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031 ( https://www.factmr.com/report/terminal-sterilization-market )

Cardiac Patch Monitor Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031 (https://www.factmr.com/report/cardiac-patch-monitor-market  )

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Increasing Demand for DNA Sequencer to Substantially Surge the Revenues Through 2031

250 Pages Cancer Profiling Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider

Fact MR analysis of cancer profiling market provides compelling insights into the factors propelling sales prospects in key segments such as Product Type, Indication, and Test Type ,End User. It provides an executive-level blueprint of key market players’ strategies and analyses their impact on overall growth projections.

According to the study, cancer profiling market revenues continue to remain consolidated in North America. Of the estimated new cases, breast cancer accounts for over 15% and colorectal cancer for about 8% new cases. As breast and colorectal cancers are few of the leading causes of death in North America, collectively they register nearly 70% of total regional cancer profiling revenues.

Focus on improving overall patient care will remain a chief growth driver. Besides this, cancer profiling market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

To offer an in-depth overview, the report provides sales projections for over 20 countries. It also identifies segments exhibiting maximum growth potential on the basis of Product Type, Indication, and Test Type.

Request a Report Sample to Gain Comprehensive Market Insights at

https://www.factmr.com/connectus/sample?flag=S&rep_id=358

Digital Transformation in Healthcare Presenting Opportunities for Cancer Profiling Market Growth

Healthcare organizations around the world are deploying digital tools to accommodating changing consumer preferences. They are pressing on solving the long-standing challenge pertaining to care model innovation.

Considering this, the focus on making healthcare affordable and more transparent will increase. Adoption of care model innovation in healthcare will have a profound impact on the cancer profiling market.

cancer profiling tests price analysis us unit by region

Key Cancer Profiling Survey Highlights and Projections

Driven by higher investment in innovation, the U.S. will emerge as the dominant Cancer Profiling market in North America, accounting for 4.7% of overall sales registered in 2028.

With the presence of some of the world’s leading healthcare companies, coupled with high spending on hospital services, the U.K. and Germany will emerge as highly lucrative pockets in Europe.

Investment towards healthcare sector expansion and focus on medical tourism will make China, Japan, and South Korea key markets within East Asia.

Speak to Research Analyst

https://www.factmr.com/connectus/sample?flag=AE&rep_id=358

Report Benefits & Key Questions Answered

Cancer Profiling Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.

Cancer Profiling Historical volume analysis: The report provides a comparison of Cancer Profiling’s historical sales and projected sales performance for 2021-2031.

DNA Sequencer Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the DNA Sequencer market. It carefully gauges the impact of changing healthcare needs of key demographics globally

Cancer Profiling Consumption by demographics: The report investigates consumer behavior affecting Cancer Profiling demand outlook for the assessment period. Effect of their keenness for digital trends on Cancer Profiling market is carefully analyzed

Post COVID consumer spending on Cancer Profiling: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Cancer Profiling market growth.

Competitive Landscape Analysis

The study offers insights into key trends affecting healthcare industry, subsequently influencing demand supply forces in the Cancer Profiling market.

  • F. Hoffmann La Roche Ltd
  • Illumina Inc
  • QIAGEN
  • Thermo Fisher Scientific Inc
  • Abbott
  • Nanostring Technologies Inc
  • Siemens AG
  • HTG Molecular Diagnostics, Inc
  • Perkin Elmer Inc
  • Agilent Technologies Inc
  • Negenomics Laboratory Inc

To offer an in-depth analysis of prevailing competition, the report offers a detailed market share analysis. In this chapter market players are segregated in terms of Tier 1, Tier 2, and Tier 3 companies. Strategies adopted by players across these categories and impact of the same on the overall market are studied at length.

Full Access of this Report Is Available at

https://www.factmr.com/checkout/358

Cancer Profiling Demand Analysis by Category

Product Type

Immunohistochemistry (IHC) Analyzers
Fluorescence In situ Hybridization (FISH) Instruments
PCR instruments
DNA Sequencer
Fragment Analyzer
Consumables
Reagents & Kits
Other Ancillary (probes, holders etc.)

By Indication

Breast Cancer
Colorectal Cancer
Ovarian Cancer
Melanoma
Kidney Cancer
Lung Cancer (including NSCLC)
Rare Cancers

By End User

Hospitals
Diagnostic Centres
Cancer Research Institutes

Region

North America
Europe
East Asia
South Asia
Oceania
Middle East and Africa

For More Insights

https://www.biospace.com/article/linear-motion-systems-sales-surged-by-increment-in-industrial-production-across-the-globe-says-fact-mr/

Cancer Profiling Market – Additional Questions Answered

In addition to the aforementioned insights, the cancer profiling market report delivers intelligent insights based on a thorough assessment of all the market facets. These insights can answer to some of the bemusing questions of the business professional interested in the cancer profiling market.

  • Which product type in the cancer profiling market will register significant demand by the end of the assessment period?
  • Which region presents considerable utilization of cancer profiling tools?
  • Among different test types, which test type will be highly sought after in the cancer profiling market during the forecast period?
  • Which end-user will register leading utilization of cancer profiling tests during the forecast period?

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

Categories
Pharmaceutical

Demand for Home-based Behavioural Health Treatment Services Is Estimated CAGR of 2.4% Over the Assessment Period

Big data and analytics will drive patient outcomes in a big way, and the coming years will witness a growing emphasis on healthcare service providers in the business of gathering and processing patient health data. Creating outcome-oriented financial models to maximize reimbursements in value-based healthcare will be a strategic shift from the traditional fees-for-services model. This implies that pharmaceutical companies will need to devise appropriate measures to optimize costs and improve the quality of patient care.

Burden of mental illness on Europe’s economy is among the largest in the world, inadvertently making it the most lucrative region for players in the behavioural health treatment market, with the region slated to account for a staggering 47% of the global market by 2027. Total cost associated with mental health treatment amounted to around US$ 668 Bn in 2018 across the EU, translating to 4% of the GDP of Europe. Taking cue from this opportunity, key players are striving to expand their treatment facilities to offer easy accessibility to patients.

For More Insights Into The Market, Request a Sample of this Report –

https://www.factmr.com/connectus/sample?flag=S&rep_id=4370

However, uneven distribution of therapy facilities and rehabilitation centres in rural regions across the globe is projected to result in sluggish growth of the behavioural health treatment market, with an estimated CAGR of 2.4% during the forecast period (2020-2027).

A senior analyst at Fact.MR opines,“Advent of on-demand service model will remain crucial for the behavioural health treatment market, especially in developing regions, on account of high social stigma related to opting for mental health therapy. Additionally, value-based subscription models offered by on-demand counselling would be easy on the pockets of patients, which is projected to drive a massive shift from hospital and outpatient-based care to home-based care.”

Key Takeaways of Behavioural Health Treatment Market Study

  • According to WHO, 800,000 suicides are recorded every year, on the back of depression and anxiety disorders. Symptoms of depression are found to be high among millennial cohort as compared to other age groups, influenced by reckless use of social media and stressful lifestyles. Revenue generation through patient base suffering from depression is projected to grow by 3.2% in 2027 over 2026.
  • Individuals will continue to show a high interest in outpatient counselling services, as these programs offer freedom of movement over inpatient hospital treatment services. Given the high relevance of this influence, outpatient counselling services are projected to witness a marginal rise, at a CAGR of around 2.7% during the forecast period.
  • Social stigma associated with mental health discourages individuals from seeking proper treatment and counselling, which could hinder behavioural health treatment market growth during the forecast period.
  • Asia Pacific is projected to record the highest growth rate of nearly 2.8% during 2020-2027, which is attributable to increase in service centres and debunking of mental health taboos through awareness campaigns by various government and non-governmental organizations.

Access Research Methodology Prepared By Experts –

https://www.factmr.com/connectus/sample?flag=S&rep_id=4370

Behavioural Health Treatment Market – Assessment of Key Segments

Disorder
  • Depression
  • Anxiety
  • Schizophrenia
  • Bipolar Disorder
  • Alcohol Use Disorders
  • Substance Use Disorders
  • Eating Disorders
  • Post-traumatic Stress Disorders
  • Others
Service
  • Inpatient Hospital Treatment Services
  • Outpatient Counselling
  • Emergency Mental Health Services
  • Home-based Treatment Services
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Full Access of this Report Is Available At

https://www.factmr.com/checkout/4370

market share estimation of key regions in behavioural health treatment market

Key Players Listed in this Comprehensive Report on the Behavioural Health Treatment Market Include

Although the behavioural health treatment market boasts of a number of organized players, numerous individual practitioners operating at regional and local levels generate a significant chunk of revenue. Lack of stringent regulations for practicing behavioural health services reduces the entry barrier in the market, and further adds a layer of fragmentation to the behavioural health treatment market.

Key focus of players to strengthen their foothold in the behavioural health treatment market remains on the expansion of inpatient care facilities. For instance, in January 2019, Acadia Healthcare announced the acquisition of Whittier Pavilion, which is an inpatient psychiatric facility with 71 beds. In May 2019, MercyOne Central Iowa and Universal Health Services, Inc. established a new facility at Iowa, with 100 beds, to offer high quality services for behavioural health.

  • Promises Behavioural Health
  • Pyramid Healthcare
  • Acadia Healthcare
  • Ascension Seton
  • CareTech Holdings PLC
  • STRATEGIC BEHAVIOURAL HEALTH
  • The MENTOR Network
  • North Range Behavioural Health
  • Universal Health Services Inc.
  • Behavioural Health Network Inc.

Explore More Trending Reports of Fact.MR

Pelvic Floor Stimulator Market Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031 ( https://www.factmr.com/report/pelvic-floor-stimulator-market )

Terminal Sterilization Market Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031 ( https://www.factmr.com/report/terminal-sterilization-market )

Cardiac Patch Monitor Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031 (https://www.factmr.com/report/cardiac-patch-monitor-market  )

Find More Valuable Insights on Behavioural Health Treatment Market

Fact.MR, in its new offering, brings to the fore an unbiased analysis of the global behavioural health treatment market, presenting historical demand data (2017-2019), and forecast statistics for the period 2020-2027. The study divulges compelling insights on the behavioural health treatment market on the basis of disorder (depression, anxiety, schizophrenia, bipolar disorder, alcohol use disorders, substance use disorders, eating disorders, post-traumatic stress disorders (PSTD), and others), service (inpatient hospital treatment services, outpatient counselling, emergency mental health services, home-based treatment services, and others), across five major regions.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
  • Tags
Categories
Pharmaceutical

Demand for Plastic Blood Collection Tubes for Liquid Biopsy Is Poised to See a Healthy Growth Outlook at 6% CAGR During 2019 – 2029

Surpassing revenues worth US$ 215 Mn in 2019, sales of blood collection tubes for liquid biopsy are poised to see a healthy growth outlook at 6% CAGR during 2019 – 2029. Despite being an essential diagnostic product in the practice of laboratory biopsy testing, the blood collection tubes for liquid biopsy market is still young, and the application scope remains majorly limited to research industry.

High product availability is limited to developed regions such as North America, Europe, and Oceania. However, increased application of blood collection tubes for liquid biopsy in genetic diagnostics and other common diagnostic procedures is likely to bolster demand for blood collection tubes for liquid biopsy in following years.

The healthcare industry is consistently witnessing an increase in the number of biopsy procedures every year, globally, due to the increasing prevalence of cancer. Growing awareness and rise in cancer screening procedures has led to the growth of the blood collection tubes for liquid biopsy market which in turn has increased the rate of early diagnosis of cancer.

For More Insights Into The Market, Request a Sample of this Report –

https://www.factmr.com/connectus/sample?flag=S&rep_id=4495

Key Segments of the Blood Collection Tubes for Liquid Biopsy Market

Fact.MR’s study on the blood collection tubes for liquid biopsy market offers information divided into four important segments-product, application, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Products
  • Plastic
  • Glass
Application
  • IVD
  • Research Use
End User
  • Healthcare Centers
  • R&D Centers
  • Diagnostic Centers
Region
  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

Access Research Methodology Prepared By Experts –

https://www.factmr.com/connectus/sample?flag=AE&rep_id=4495

Key Takeaways – Blood Collection Tubes for Liquid Biopsy

  • Healthcare centers would show remarkable growth in adoption of blood collection tubes for liquid biopsy owing to the rise in number of research activities.
  • Increasing prevalence of cancers will remain one of the major factors responsible for the growth of the blood collection tubes for liquid biopsy market.
  • Blood collection tubes for liquid biopsy market is a fragmented landscape.
  • Growing demand for single needle penetration for multiple tests is identified as the key growth engine, pushing adoption of blood collection tubes for liquid biopsy.

Key Players

  • Roche
  • Streck
  • Preanalytix
  • Norgen Biotek
  • Biocept

blood collection tubes for liquid biopsy market 02

Plastic Tubes Remain Highly Sought-after

On back of higher safety standards, plastic blood collection tubes for liquid biopsy will continue to gather preference over their glass counterparts. The former remains preferred for their greater reliability during routine clinical chemistry analysis, tumor screening, biopsy tests and chemotherapeutic drug monitoring. The shatter-resistant plastic further reduces the risk of exposure to pathogens and contamination.

Attractiveness of Asian Markets Intact

Growth opportunities for the blood collection tubes for liquid biopsy market players is picking up the pace in the East and South Asian regions. Increasing availability of economically affordable blood collection tubes would also be a significant booster to market growth. A large number of local manufacturers, particularly in China, Japan, and India, are increasing the scope for manufacturers and boosting the blood collection tubes for liquid biopsy market growth.

Full Access of this Report Is Available at

https://www.factmr.com/checkout/4495

Know More About Blood Collection Tubes for Liquid Biopsy Market

Fact.MR’s business intelligence also underlines groundbreaking insights into the competitive scenario of the blood collection tubes for liquid biopsy market, along with highlights of manufacturers’ differential strategies. The blood collection tubes for liquid biopsy market is majorly covered by the players offering conventional blood collection tubes for liquid biopsy. The key players’ operating in the blood collection tubes for liquid biopsy market will continue to focus on delivering of their products through direct sales and distribution channels.

Key Questions Answered in Fact.MR’s Blood Collection Tubes for Liquid Biopsy Market Report

  • Which regions will continue to remain the most profitable for blood collection tubes for liquid biopsy market players?
  • Which factors will induce a change in the demand for blood collection tubes for liquid biopsy during the assessment period?
  • How will the changing trends impact the blood collection tubes for liquid biopsy market?
  • How will the market players capture the untapped market opportunities in the blood collection tubes for liquid biopsy market?
  • How local players’ products will impact the adoption of blood collection tubes for liquid biopsy?

Explore More Trending Reports of Fact.MR

Pelvic Floor Stimulator Market Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031 ( https://www.factmr.com/report/pelvic-floor-stimulator-market )

Terminal Sterilization Market Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031 ( https://www.factmr.com/report/terminal-sterilization-market )

Cardiac Patch Monitor Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031 (https://www.factmr.com/report/cardiac-patch-monitor-market  )

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com